메뉴 건너뛰기




Volumn 16, Issue 15, 2008, Pages 7167-7176

Synthesis and evaluation of pyrazolo[3,4-b]pyridines and its structural analogues as TNF-α and IL-6 inhibitors

Author keywords

Anti inflammatory; IL 6; Pyrazolo 3,4 b pyridines; TNF

Indexed keywords

3 (2 HYDROXY 5 METHYLBENZOYL)BENZIMIDAZO[1,2 A]PYRIMIDINE; 3 PROPYL 3 OL BENZO[4,5]IMIDAZO[1,2 A]PYRIMIDINE; 5 (1 ETHOXY 2,4 DIMETHOXYLBUTYL 3 OL) 3 (4 METHOXYPHENYL) 1 PHENYL 1H PYRAZOLO[3,4 B]PYRIDINE; 5 (1 ETHOXY 2,4 DIMETHOXYLBUTYL 3 OL) 3 METHYL 1 PHENYL 1H PYRAZOLO[3,4 B]PYRIDINE; 5 (1 ETHOXYBUTYL 2,3,4 TRIOL) 3 (4 HYDROXY PHENYL) 1 PHENYL 1H PYRAZOLO[3,4 B]PYRIDINE; 5 (1,2,4 TRIMETHOXYLBUTYL 3 OL) 1,3 DIMETHYL 1H PYRAZOLO[3,4 B]PYRIDINE; 5 (2 HYDROXY 3,5 DIMETHYLBENZOYL) 3 METHYL 1 PHENYL 1H PYRAZOLO[3,4 B]PYRIDINE; 5 (2 HYDROXY 5 FLUOROBENZOYL) 1,3 DIMETHYL 1H PYRAZOLO[3,4 B]PYRIDINE; 5 (2 HYDROXY 5 METHYLBENZOYL) 1,3 DIMETHYL 1H PYRAZOLO[3,4 B]PYRIDINE; 5 (2 HYDROXY 5 METHYLBENZOYL) 3 (4 METHOXYPHENYL) 1 PHENYL 1H PYRAZOLO[3,4 B]PYRIDINE; 5 (2 HYDROXY 5 METHYLBENZOYL) 3 METHYL 1 PHENYL 1H PYRAZOLO[3,4 B]PYRIDINE; 5 (2 HYDROXY 5 METHYLBENZOYL) 3 METHYLISOXAZOLO[5,4 B]PYRIDINE; 5 (2 HYDROXY 5 METHYLBENZOYL) 3 PHENYLISOXAZOLO[5,4 B]PYRIDINE; 5 (3 ACETOXY)PROPYL 1 ETHYL 1H PYRAZOLO[3,4 B]PYRIDINE; 5 PROPYL 3 OL 1,3 DIMETHYL 1H PYRAZOLO[3,4 B]PYRIDINE; 5 PROPYL 3 OL 3 (4 METHOXYPHENYL) 1 PHENYL 1H PYRAZOLO[3,4 B]PYRIDINE; 5 PROPYL 3 OL 3 METHYL 1 PHENYL 1H PYRAZOLO[3,4 B]PYRIDINE; 6 (1,2,4 TRIMETHOXYBUTYL 3 OL) 2 4 TOLYLPYRAZOLO[1,5 A]PYRIMIDINE; 6 (2 HYDROXY 5 METHYLBENZOYL) 2 4 TOLYLPYRAZOLO[1,5 A]PYRIMIDINE; 6 (2 HYDROXY 5 METHYLBENZOYL)PYRIDO[2,3 D]PYRIMIDINE 2,4 (1H,3H)DIONE; 6 (3 ACETOXY)PROPYLPYRAZOLO[1,5 A]PYRIMIDINE; 6 (3 ACETOXYPROPYL)[1,2,4]TRIAZOLO[1,5 A]PYRIMIDINE; 6 (3 HYDROXYPROPYL)PYRIDO[2,3 D]PYRIMIDINE 2,4 (1H,3H)DIONE; 6 PROPYL 3 OL 2 4 TOLYLPYRAZOLO[1,5 A]PYRIMIDINE; CYTOKINE RECEPTOR ANTAGONIST; DEXAMETHASONE; INTERLEUKIN 6 INHIBITOR; PYRAZOLO[3,4 B]PYRIDINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 48649108824     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2008.06.042     Document Type: Article
Times cited : (98)

References (33)
  • 5
    • 48649088655 scopus 로고    scopus 로고
    • Dominic S. C. R. Seminars in Arthritis and Rheumatism in press, (doi: 10.1016/j.semarthrit.2008.01.006).
    • Dominic S. C. R. Seminars in Arthritis and Rheumatism in press, (doi: 10.1016/j.semarthrit.2008.01.006).
  • 16
    • 48649104466 scopus 로고    scopus 로고
    • Abe, Y.; Ohne, K.; Inoue, M.; Okumura, M. US2006/0004003 A1 2006, (Astellas Pharma Inc., Tokyo, Japan).
    • Abe, Y.; Ohne, K.; Inoue, M.; Okumura, M. US2006/0004003 A1 2006, (Astellas Pharma Inc., Tokyo, Japan).
  • 17
    • 48649097061 scopus 로고    scopus 로고
    • Inoue, M.; Hashimoto, K. JP 1991204877 1991, (Otsuka Pharmaceutical Factory, Inc. Tokushima, Japan).
    • Inoue, M.; Hashimoto, K. JP 1991204877 1991, (Otsuka Pharmaceutical Factory, Inc. Tokushima, Japan).


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.